Angiosarcoma — Trials

Angiosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

53 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 16
Recruiting: 10
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Memorial Sloan Kettering Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03512834	Paclitaxel-Avelumab for Angiosarcoma(ASAP)	unknown	Phase 2	32	Sung Yong OhOTHER	1	Jul 11, 2018	clinicaltrials
NCT01786889	Identification, Molecular Epidemiology Angiosarcoma of the Liver France(ANGIHE)	unknown	N/A	9	Centre Oscar LambretOTHER	1	Jul 29, 2016	clinicaltrials